Nephrocare Health Services Ltd vs Qms Medical Allied Services Ltd Stock Comparison
Nephrocare Health Services Ltd vs Qms Medical Allied Services Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Nephrocare Health Services Ltd is ₹ 597.3 as of 23 Oct 15:30
. The P/E Ratio of Nephrocare Health Services Ltd changed from 66 on March 2026 to 0 on March 2023 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of QMS Medical Allied Services Ltd changed from 23.2 on March 2024 to 0 on March 2023 . This represents a CAGR of -100.00% over 6 years The Market Cap of Nephrocare Health Services Ltd changed from ₹ 5072 crore on March 2026 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 4 yearsThe Market Cap of QMS Medical Allied Services Ltd changed from ₹ 208.93 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 6 years The revenue of Nephrocare Health Services Ltd for the Jun '26 is ₹ 289.21 crore as compare to the Mar '26 revenue of ₹ 277.18 crore. This represent the growth of 4.34% The revenue of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 57.28 crore as compare to the Mar '26 revenue of ₹ 44.65 crore. This represent the growth of 28.29% The ebitda of Nephrocare Health Services Ltd for the Jun '26 is ₹ 67.78 crore as compare to the Mar '26 ebitda of ₹ 62.24 crore. This represent the growth of 8.9% The ebitda of QMS Medical Allied Services Ltd for the Jun '26 is ₹ 8.73 crore as compare to the Mar '26 ebitda of ₹ 6.13 crore. This represent the growth of 42.41% The net profit of Nephrocare Health Services Ltd changed from ₹ 20.11 crore to ₹ 31.97 crore over 7 quarters. This represents a CAGR of 30.33%
The net profit of QMS Medical Allied Services Ltd changed from ₹ 2.4 crore to ₹ 3.96 crore over 9 quarters. This represents a CAGR of 24.93%
The Dividend Payout of Nephrocare Health Services Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of QMS Medical Allied Services Ltd changed from 9.92 % on March 2024 to 144.54 % on March 2026 . This represents a CAGR of 144.24% over 3 years .
About Nephrocare Health Services Ltd
Nephrocare Health Services Limited was incorporated as 'Nephrocare Health Services Private Limited', a private limited company at Hyderabad with a certificate of incorporation issued by the Assistant Registrar of Companies, Andhra Pradesh on December 18, 2009.
Company was converted into a public limited company and the name was changed to 'Nephrocare Health Services Limited' with a fresh certificate of incorporation dated June 18, 2025 issued by the Registrar of Companies, Central Registration Centre.
Company offer comprehensive dialysis care through a network of clinics - from diagnosis to treatment and wellness programs including haemodialysis, home and mobile dialysis, supported by pharmacy.
The Company began journey in 2010 with the launch of its first dialysis clinic in Hyderabad.
It launched first Public Private Partnership (PPP) clinic in Sananth Nagar, Hyderabad in 2012; acquired 100% stake in DaVita Care (India) Private Limited, the Indian arm of DaVita Care Pte Ltd.
About QMS Medical Allied Services Ltd
QMS Medical Allied Services Limited was incorporated as 'QMS Medical Allied Services Private Limited' on September 14, 2017.
The status of the Company was changed to Public Limited and name of the Company changed to QMS Medical Allied Services Limited on October 22, 2020.
The Company is engaged in marketing, trading and distribution of a wide range of Medical Products, Medical and Surgical Instruments, Medical Equipments & Accessories and Medical Devices.
Presently, the Company manage a wide range portfolio of products sold under brand 'Qdevices' and also distribution for other brands such as 3M, Heine, Rossmax etc.
Further, it organizes and provides medical education to members belonging to medical fraternity like, physicians, nurses, nurse practitioners, physician assistants, pharmacists, and other healthcare professionals by partnering with renowned medical education institutions such as EACME.
FAQs for the comparison of Nephrocare Health Services Ltd and QMS Medical Allied Services Ltd
Which company has a larger market capitalization, Nephrocare Health Services Ltd or QMS Medical Allied Services Ltd?
Market cap of Nephrocare Health Services Ltd is 6,006 Cr while Market cap of QMS Medical Allied Services Ltd is 333 Cr
What are the key factors driving the stock performance of Nephrocare Health Services Ltd and QMS Medical Allied Services Ltd?
The stock performance of Nephrocare Health Services Ltd and QMS Medical Allied Services Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Nephrocare Health Services Ltd and QMS Medical Allied Services Ltd?
As of October 25, 2026, the Nephrocare Health Services Ltd stock price is INR ₹597.3. On the other hand, QMS Medical Allied Services Ltd stock price is INR ₹172.21.
How do dividend payouts of Nephrocare Health Services Ltd and QMS Medical Allied Services Ltd compare?
To compare the dividend payouts of Nephrocare Health Services Ltd and QMS Medical Allied Services Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.